(NASDAQ:KURA), SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on November 3, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards […]
(NASDAQ:RLMD), CORAL GABLES, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) — Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications, today announced plans to host a conference call and webcast on Thursday, November 13, 2025 at 4:30 PM ET to discuss financial
Copyseeker announced today the launch of its Model Context Protocol (MCP) server, bringing reverse image search directly into AI assistants like ChatGPT, Claude, and Gemini. No more tab switching. No more copying and pasting URLs. Just seamless visual search right where users are already working. The timing couldn't be better. As millions of professionals now
(NasdaqGM:NEXN), NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for the three and nine months ended September 30, 2025, before the U.S. market opens on Thursday, November
F&G Annuities & Life, Inc. (NYSE:FG) (“F&G” or the “Company”) today announced that its Board of Directors has declared an increase in the Company's quarterly cash dividend of 14%, to $0.25 per common share, from the previous quarterly cash dividend of $0.22 per common share. The dividend will be payable December 31, 2025, to stockholders
Soligenix, Inc.(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,announced today its recent accomplishments and financial results for the quarter ended September 30, 2025. https://mma.prnewswire.com/media/1768046/Soligenix_Logo.jpg “We remain focused on multiple upcoming milestones before year-end, including top-line results
The acquisition expands Laborie's obstetrics portfolio and demonstrates the company's commitment to delivering innovative, proven solutions to physicians and patients globally. Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (“Laborie”) announced it has entered into an agreement with Organon, a global healthcare company with a mission to deliver impactful medicines and solutions
Sunstone Hotel Investors, Inc. (the “Company” or “Sunstone”) (NYSE: SHO) today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Operational Results (as compared to Third Quarter 2024): — Net Income: Net income was $1.3 million as compared to $3.2 million. — Total Portfolio RevPAR: Total Portfolio RevPAR increased 2.0% to
Fidelity National Financial, Inc. (NYSE:FNF) (“FNF” or the “Company”) today announced that its Board of Directors has declared an increase in the Company's quarterly cash dividend of 4%, to $0.52 per common share, from the previous quarterly cash dividend of $0.50 per common share. The dividend will be payable December 31, 2025, to stockholders of
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025, at Noon GMT (7 a.m. ET). https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg A live webcast of the presentation can be